SEC Filings | BioNTech

Filing date	Description	Form	View
12 June 2020	Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy	DRS	0000950123-20-006236.pdf 0000950123-20-006236.rtf 0000950123-20-006236.xls View HTML
11 June 2020	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	0001564590-20-028940.pdf 0001564590-20-028940.rtf 0001564590-20-028940.xls View HTML
12 May 2020	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	0001564590-20-024741.pdf 0001564590-20-024741.rtf 0001564590-20-024741.xls View HTML
6 May 2020	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	0001193125-20-134949.pdf 0001193125-20-134949.rtf 0001193125-20-134949.xls View HTML
5 May 2020	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	0001564590-20-020990.pdf 0001564590-20-020990.rtf 0001564590-20-020990.xls View HTML
29 April 2020	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	0001564590-20-019419.pdf 0001564590-20-019419.rtf 0001564590-20-019419.xls View HTML
22 April 2020	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	0001564590-20-017808.pdf 0001564590-20-017808.rtf 0001564590-20-017808.xls View HTML
22 April 2020	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	0001564590-20-017810.pdf 0001564590-20-017810.rtf 0001564590-20-017810.xls View HTML
9 April 2020	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	0001564590-20-016001.pdf 0001564590-20-016001.rtf 0001564590-20-016001.xls View HTML
2 April 2020	Form of prospectus reflecting facts events constituting substantive change from last form	424B3	0001193125-20-096022.pdf 0001193125-20-096022.rtf 0001193125-20-096022.xls View HTML

Data provided by Kaleidoscope.